Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 4/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28846419 | 1.00 | HPRT1 (0.50) | HPRT1CYP3A4LMNAMAPTAPEX1 | |
| SCHEMBL2852558 | 0.91 | CYP3A4 (0.47) | HPRT1CYP3A4LMNAMAPTAPEX1 | |
| SCHEMBL29871387 | 0.91 | CYP3A4 (0.47) | HPRT1CYP3A4LMNAMAPTAPEX1 | |
| SCHEMBL25647644 | 0.82 | CYP3A4 (0.43) | HPRT1CYP3A4LMNAMAPTMAPK1 | |
| SCHEMBL11565679 | 0.79 | ALDH1A1 (0.41) | CYP3A4LMNAMAPTALDH1A1HSD17B10 | |
| SCHEMBL29966574 | 0.79 | ALDH1A1 (0.38) | CYP3A4LMNAMAPTALDH1A1HSD17B10 | |
| SCHEMBL6536967 | 0.79 | ALDH1A1 (0.38) | CYP3A4LMNAMAPTALDH1A1HSD17B10 | |
| Oxazole SCHEMBL7862230 | 0.76 | CYP3A4 (0.38) | CYP3A4LMNAMAPTAPEX1MAPK1 | |
| SCHEMBL17691870 | 0.76 | ERN1 (0.39) | HPRT1CYP3A4LMNAMAPTMAPK1 | |
| SCHEMBL9191805 | 0.75 | RIPK2 (0.45) | LMNAMAPTNPC1RECQLRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240081141-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-03-07 | — | — | US | claimed |
| US-20230337525-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | claimed |
| US-20240081141-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-03-07 | — | — | US | disclosed |
| US-20230337525-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
| CN-115057830-A | Method for synthesizing 2-aryl benzothiazole | 辽宁科技大学 | 2022-09-16 | — | — | CN | disclosed |
| CN-101185027-B | Graft pattern forming method and conductive pattern forming method | FUJIFILM CORP. (JP) | 2011-11-30 | — | — | CN | disclosed |
| CN-101338416-B | Shading member, manufacturing method thereof, film and photo mask using the member | FUJI PHOTO FILM CO LTD | 2011-04-20 | — | — | CN | disclosed |
| US-20090092766-A1 | GRAFT PATTERN FORMING METHOD AND CONDUCTIVE PATTERN FORMING METHOD | FUJIFILM CORPORATION (JP) | 2009-04-09 | — | — | US | disclosed |
| CN-101387714-A | Shading member, manufacturing method thereof, film and photo mask using the member | FUJIFILM CORP (JP) | 2009-03-18 | — | — | CN | disclosed |
| CN-101338416-A | Shading member, manufacturing method thereof, film and photo mask using the member | FUJIFILM CORP (JP) | 2009-01-07 | — | — | CN | disclosed |
| CN-101266408-A | Laminating body, grafting film forming method using the same and forming method for grafting pattern | FUJIFILM CORP (JP) | 2008-09-17 | — | — | CN | disclosed |
| US-20030180673-A1 | Production process of silver halide photographic emulsion and silver halide photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. | 2003-09-25 | — | — | US | disclosed |
| US-20030170575-A1 | Silver halide photographic material | FUJI PHOTO FILM CO., LTD. | 2003-09-11 | — | — | US | disclosed |
| US-6610466-B2 | Exhibits increased light absorption and light absorption intensity and which has sensitizing dyes adsorbed in multilayer form stably even in the presence of an organic solvent. | FUJI PHOTO FILM CO., LTD. (JP) | 2003-08-26 | — | — | US | disclosed |
| US-6521401-B1 | Spectrally sensitizing with dye that does not have electric charge or forms an inner salt | FUJI PHOTO FILM CO., LTD. (JP) | 2003-02-18 | — | — | US | disclosed |
| US-20020177087-A1 | Silver halide photographic lightsensitive material | FUJIFILM CORPORATION (JP) | 2002-11-28 | — | — | US | disclosed |
| US-6465166-B1 | HIGH SPEED SILVER HALIDE PHOTOGRAPHIC EMULSION WHEREIN THE GRAIN AGGLOMERATION IS PREVENTED AND PHOTOGRAPHIC MATERIAL REDUCED IN RESIDUAL DYE COLOR AFTER PROCESSING | FUJI PHOTO FILM. CO., LTD. (JP) | 2002-10-15 | — | — | US | disclosed |
| CN-1340739-A | Silver halide photographic light-sensitive material | FUJI PHOTO FILM CO LTD (JP) | 2002-03-20 | — | — | CN | disclosed |
| US-20020012892-A1 | Methine compound-containing silver halide photographic emulsion and photographic material using the same | FUJIFILM CORPORATION (JP) | 2002-01-31 | — | — | US | disclosed |
| EP-1067430-A1 | Silver halide photographic emulsion and photographic light-sensitive material using the same | FUJI PHOTO FILM CO., LTD. (JP) | 2001-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240081141-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, ICOSLG | HPRT1 224/4885CYP3A4 1118/4885LMNA 4072/4885 |
| US-20230337525-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OXER1 | HPRT1 2285/4885CYP3A4 124/4885LMNA 2110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.